Nanoveu Limited (ASX:NVU)
0.0580
-0.0050 (-7.94%)
Sep 3, 2026, 4:10 PM AEST
Nanoveu Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.02 | 0.3 | 0.01 | 0.1 | 0.16 | 0.78 | |
Revenue Growth | -91.54% | 4229.72% | -93.30% | -35.72% | -79.58% | 112.37% |
Cost of Revenue | 0.83 | 0.93 | -0 | 0.08 | 0.09 | 0.39 |
Gross Profit | -0.8 | -0.63 | 0.01 | 0.03 | 0.07 | 0.39 |
Selling, General & Admin | 6.47 | 4.81 | 2.16 | 2.03 | 2.64 | 2.1 |
Research & Development | 1.04 | 0.76 | 0.05 | 0.02 | 0.01 | 0.23 |
Other Operating Expenses | -0.01 | -0.01 | -0.02 | -0.03 | -0.02 | -0.07 |
Operating Expenses | 8.08 | 6.99 | 2.86 | 2.17 | 2.52 | 2.34 |
Operating Income | -8.88 | -7.62 | -2.85 | -2.15 | -2.45 | -1.96 |
Interest Expense | -0.02 | -0.01 | -0.01 | -0.01 | -0.18 | -0.3 |
Interest & Investment Income | 0.08 | 0.03 | 0.01 | - | 0 | 0 |
Other Non Operating Income (Expenses) | -0 | - | - | - | - | - |
EBT Excluding Unusual Items | -8.82 | -7.6 | -2.85 | -2.16 | -2.63 | -2.25 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.07 |
Asset Writedown | -0.04 | - | - | - | -0.05 | - |
Pretax Income | -8.86 | -7.6 | -2.85 | -2.16 | -2.67 | -2.32 |
Earnings From Continuing Operations | -8.86 | -7.6 | -2.85 | -2.16 | -2.67 | -2.32 |
Minority Interest in Earnings | 0.25 | 0.18 | 0.04 | - | - | - |
Net Income | -8.61 | -7.42 | -2.81 | -2.16 | -2.67 | -2.32 |
Net Income to Common | -8.61 | -7.42 | -2.81 | -2.16 | -2.67 | -2.32 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,012 | 826 | 474 | 375 | 230 | 174 |
Shares Outstanding (Diluted) | 1,012 | 826 | 474 | 375 | 230 | 174 |
Shares Change | 68.80% | 74.37% | 26.20% | 62.95% | 32.76% | 28.55% |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.87 | -5.92 | -1.84 | -2.01 | -1.91 | -2.04 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.01 | -0.01 |
Gross Margin | - | -212.42% | 153.21% | 24.64% | 45.35% | 49.48% |
Operating Margin | -37906.79% | -2560.73% | -41433.29% | -2092.18% | -1536.74% | -250.47% |
Profit Margin | -36772.81% | -2494.55% | -40880.40% | -2106.47% | -1675.82% | -297.05% |
Free Cash Flow Margin | -33616.71% | -1990.16% | -26807.65% | -1956.33% | -1195.74% | -261.23% |
EBITDA | -8.9 | -7.59 | -2.81 | -2.1 | -2.41 | -1.91 |
EBITDA Margin | - | - | - | - | - | -244.02% |
D&A For EBITDA | -0.02 | 0.03 | 0.03 | 0.05 | 0.05 | 0.05 |
EBIT | -8.88 | -7.62 | -2.85 | -2.15 | -2.45 | -1.96 |
EBIT Margin | - | - | - | - | - | -250.47% |
Revenue as Reported | 0.02 | 0.3 | 0.01 | 0.1 | 0.16 | 0.78 |